Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003-2014.

ABSTRACT: Improved understanding of the natural history of cervical cancer has led to changes in screening recommendations, including the addition of the human papillomavirus (HPV) testing as an option in routine screening. Most studies of screening trends have used national self-reported survey data. To better understand recent trends in cervical cancer screening, including cytology (Papanicolaou, or Pap, tests) and human papillomavirus co-tests (HPV + Pap test), we used healthcare claims data to examine screening practices and trends. We analyzed screening among commercially-insured females ages 18-65 during 2005-2014 who were continuously enrolled during three or more contiguous calendar years, to identify those who received cervical cancer screening with a Pap test or co-test. We examined screen

SUBMITTER: Watson M 

PROVIDER: S-EPMC5840841 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature